Business Paid
Pure Biologics expects partner agreement closed in H1 2024
19:02
Pure Biologics aims to sign a partnering agreement for projects PB004 and/or PB003G by mid-2024, with discussions ongoing and interest from about 10 entities. CEO Filip Jeleń anticipates favorable terms, emphasizing a sustainable partnership over an exceptionally high upfront fee.
This article is for subscribers
Warsaw Business Journal subscribers get the full archive (12,248 articles going back to 1995) and the print edition.
SubscribeOr try Poland A.M. free for 7 days, the daily briefing, or see all plans and prices.
